Merz Pharmaceuticals

Pharma

Merz hires Stiefel executive Humphries to become its CEO for North America

Merz Pharma Group‘s new CEO for North America comes from GlaxoSmithKline (NYSE:GSK) subsidiary Stiefel Laboratories. Starting today, William Humphries will oversee Merz’s three North American companies: Merz Pharmaceuticals, Merz Aesthetics and Merz Pharma Canada. Humphries will also oversee Germany-based Merz’s global medical dermatology business. Humphries’ background is particularly suited to the dermatology responsibilities. Humphries joins […]

By Frank Vinluan

Pharma

Court puts wrinkle in Merz attempt to compete against Allergan’s Botox

The Botox alternative developed by Merz Pharmaceuticals will remain barred from the market until next January unless the company convinces the court to modify restrictions imposed following a ruling that Merz stole trade secrets from a competitor. A federal judge in California last week ruled that Merz Pharmaceuticals and Merz Aesthetics took company information from […]

By Frank Vinluan

Beyond Analytics: How Sellers Dorsey is Hard-Coding Value into Medicaid Policy [Video]

How to turn analytics into actual policy outcomes.

By Sellers Dorsey and MedCity News